0

Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC

Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC

Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC

By May 2, 2024

Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC

Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC

Current Status
Not Enrolled
Price
Free
Get Started

This course discusses how the outcome of the combination regimen of chemotherapy and atezolizumab and subsequent treatment sequences upon patients with extensive-stage small call lung cancer (SCLC).

Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.